Skip to content Skip to footer
Subscribe Now

VIEWPOINTS

PharmaShots Interview Medicago’s Brian Ward Shares Insights on the Data of Plant-Based COVID-19 Vaccine
PharmaShots Interview: Medicago’s Brian Ward Shares Insights on the Data of Plant-Based COVID-19 Vaccine
In an interview with PharmaShots, Brian Ward, Medical Officer at Medicago shares his views on the P-III study of plant-based COVID-19 vaccine in combination with GSK’s pandemic adjuvant for the treatment of COVID-19  Shots: The company reported efficacy and safety results from the P-III study of Medicago’s plant-based COVID-19 vaccine candidate + GSK’s pandemic adjuvant in ~24,000 adults aged ≥18yrs. across Canada, US, UK,…
January 12, 2022
Viewpoints_Dr. Justin Odegaard_Dr. Yoshiaki Nakamura
PharmaShots Interview: Guardant Health’s Justin Odegaard Shares Insights on the Data of Guardant360 Liquid Biopsy Test Published in Nature Medicine
In an interview with PharmaShots, Justin Odegaard, Vice President of Clinical Development and a Laboratory Director at Guardant Health & Yoshiaki Nakamura, Staff Physician in the Department of Gastroenterology and Gastrointestinal Oncology shared their views on the benefits of using the Guardant360 liquid biopsy test in P-II (TRIUMPH) study for HER2-driven metastatic colorectal cancer Shots: The P-II (TRIUMPH) study evaluates pertuzumab +…
January 5, 2022
PharmaShots Interview Janssen’s Alyssa Johnsen Shares Insights on the New Clinical data of Tremfya (guselkumab) Presented at ACR 2021 and Published in Arthritis & Rheumatology
PharmaShots Interview: Janssen’s Alyssa Johnsen Shares Insights on the New Clinical data of Tremfya (guselkumab) Presented at ACR 2021 and Published in Arthritis & Rheumatology
In an interview with PharmaShots, Alyssa Johnsen, MD, Ph.D., Vice President, Rheumatology and Maternal-Fetal Health Disease Area Leader at Janssen Research & Development shares her views on the P-III DISCOVER-1 & 2 Studies of Tremfya (guselkumab) for the treatment of psoriatic arthritis in ACR 2021 and published in Arthritis & Rheumatology Shots: The P-III DISCOVER-1 & 2 trials evaluate Tremfya (SC) vs PBO in 381 & 739…
January 4, 2022
PharmaShots Interview Alto Neuroscience’s Dr. Amit Etkin Shares Insights on the Future of Psychiatric Medicines
PharmaShots Interview: Alto Neuroscience’s Dr. Amit Etkin Shares Insights on the Future of Psychiatric Medicines
In an interview with PharmaShots, Dr. Amit Etkin, CEO and Founder of Alto Neuroscience shared his views on its clinical stage pipeline in the emerging hot precision psychiatry space. He also put his views on the funding received by the company for the development of its pipeline. Shots: Using precision psychiatry, the company’s human data R&D platform identifies brain biomarkers…
January 3, 2022
Viewpoints_Joe Eazor
PharmaShots Interview: Clario’s Joe Eazor Shares Insight on the Clinical Trial Innovation and Evidence
In an interview with PharmaShots, Joe Eazor, CEO at Clario share his views on the ERT’s merger with Bioclinica to become Clario for clinical trial innovation and evidence ERT & Bioclinica merged to become Clario, following its Apr 2021 merger agreement & to generate the clinical evidence, empower the patients &  transform their lives by providing better evidence Clario combines Bioclinica's expertise in imaging,…
December 30, 2021
Viewpoints_Shannon Burke
PharmaShots Interview: Synchrony’s Shannon Burke Shares Insight on Healthcare Consumerism
In an interview with PharmaShots, Shannon Burke, Synchrony Senior Vice President, and General Manager, Health Systems, share her views on healthcare financing & empowers the patients to pay for their healthcare Synchrony’s CareCredit card is a comprehensive healthcare financial solution that is designed for health and wellness needs. The CareCredit solution helps health systems, reduce accounts receivable, increase revenue,…
December 29, 2021
Viewpoints_Andrew Hall
PharmaShots Interview: IMV’s Andrew Hall Shares Insight on DPX Technology for Bladder and Ovarian Cancer
In an interview with PharmaShots, Andrew Hall, CEO at IMV share his views on the data of  DPX delivery platform in the bladder and ovarian cancer, presented in two e-posters at the AACR-NCI-EORTC virtual conference Shots: The company has reported additional data to support the immunotherapeutic capabilities of its DPX technology. In pre-clinical/clinical data, DPX technology generates peptide-specific, T cell-based immune…
December 28, 2021
Viewpoints_Matt Walz
PharmaShots Interview: Trialbee’s Matt Walz Shares Insight on Trialbee Honey Platform
In an interview with PharmaShots, Matt Walz, CEO at Trialbee share his views on the launch of the Trialbee Honey platform to empower patient recruitment Shots: Trialbee launched Trialbee Honey that allows to track, measure, and analyze all patient enrollment activities in clinical trials The platform is designed to address clinical research and trial barriers by using data to optimize the patient experience,…
December 22, 2021
Viewpoints_Anthony Ho
PharmaShots Interview: QIAGEN’s Anthony Ho Shares Insight on the US Government Contract to Boost the Production of PCR Tests for NeuMoDx Systems
In an interview with PharmaShots, Anthony Ho, Global Head of Strategic Planning for Molecular Diagnostics at QIAGEN share his views on the winner of the $3.4M US DOD contract to increase the production of COVID-19 PCR test Shots: QIAGEN has received a $3.4M contract from the US DOD in coordination with the Department of HHS to increase the production capacity for…
December 21, 2021
Load more